|
RABIF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11189999996153E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23309999999766E-06 |
| Normal-vs-Stage2 |
3.672200E-02 |
| Normal-vs-Stage3 |
1.582680E-03 |
| Normal-vs-Stage4 |
6.038600E-03 |
| Stage1-vs-Stage2 |
3.680600E-01 |
| Stage1-vs-Stage3 |
5.981800E-01 |
| Stage1-vs-Stage4 |
8.058000E-01 |
| Stage2-vs-Stage3 |
6.792600E-01 |
| Stage2-vs-Stage4 |
4.181200E-01 |
| Stage3-vs-Stage4 |
5.838800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59749999995018E-06 |
| Normal-vs-AfricanAmerican |
1.574320E-02 |
| Normal-vs-Asian |
3.75430000000287E-05 |
| Caucasian-vs-AfricanAmerican |
7.327200E-01 |
| Caucasian-vs-Asian |
7.045800E-02 |
| AfricanAmerican-vs-Asian |
4.028600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.875100E-03 |
| Normal-vs-Female |
3.16740000005922E-07 |
| Male-vs-Female |
1.221770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81700000001506E-06 |
| Normal-vs-Age(41-60Yrs) |
7.579200E-04 |
| Normal-vs-Age(61-80Yrs) |
8.903800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.097200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.300560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.268000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.847600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.019600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.010400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.778000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.126600E-01 |
| Classical-VS-Follicular |
7.22170101496999E-11 |
| Classical-VS-Other |
1.574040E-02 |
| Classical-VS-Normal |
5.81479975281241E-10 |
| Tall-VS-Follicular |
1.430790E-04 |
| Tall-VS-Other |
1.591900E-02 |
| Tall-VS-Normal |
1.173770E-04 |
| Follicular-VS-Other |
5.766200E-01 |
| Follicular-VS-Normal |
5.390800E-01 |
| Other-VS-Normal |
5.578400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.061100E-03 |
| Normal-vs-N1 |
5.182200E-03 |
| N0-vs-N1 |
1.992020E-01 |
|
|
